Ver Protocolo, Seccion 7.1

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis

A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ROXADUSTAT IN THE TREATMENT OF ANEMIA IN DIALYSIS PATIENTS